Application for quotation of +securities

The document "Application for quotation of +securities" was lodged with ASX on November 11, 2021. Please click to review the full announcement at ASX.


Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 5 November 2021 and 11 November 2021 the Company issued 14,490,291 fully…


Response to ASX Price Query

The document "Response to ASX Price Query" was lodged with ASX on 9 November, 2021. Please click to review the full announcement at ASX.


Application for quotation of +securities

The document "Application for quotation of +securities" was lodged with ASX on 4 November 2021. Please click to review the full announcement at ASX.


Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 29 October 2021 and 4 November 2021 the Company issued 7,075,649 fully paid…


Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 22 October 2021 and 28 October 2021 the Company issued 5,730,814 fully paid…


Quarterly Activity Report — Quarter Ending 30 September 2021

Q3 highlights: Sites added for MagSense® HER2 Breast Cancer Phase I Study Experienced Chief Development Officer added to Management Team Joint Development…


Q&A with Chief Development Officer Yalia Jayalakshmi, Ph.D.

In this video, Chief Development Officer Yalia Jayalakshmi, Ph.D. explains why she joined Imagion Biosystems, the urgency of the company's mission, and the…


Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 15 October 2021 and 21 October 2021 the Company issued 3,904,910 fully paid…


Application for quotation of +securities

The document "Application for quotation of +securities" was lodged with ASX on 21 October, 2021. Please click to review the full announcement at ASX.